enGene Therapeutics (ENGN) Return on Invested Capital [ROIC] (2023 - 2026)
enGene Therapeutics' Return on Invested Capital [ROIC] came in at -50.80% for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 8.19 percentage points from -42.61% a year earlier and down 5.70 percentage points from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Return on Invested Capital [ROIC] (2023 - 2026) Analysis & Trends
For FY2024 (ended Oct 31, 2024), enGene Therapeutics' Return on Invested Capital [ROIC] was -32.95%, up 281.71 percentage points from FY2023.
- Going back by fiscal year, Return on Invested Capital [ROIC] was -314.66% in FY2023.
- The five-year range for quarterly Return on Invested Capital [ROIC] is -183.99% (fiscal Q4 2023) to -21.30% (fiscal Q3 2024).
- Year-over-year, Return on Invested Capital [ROIC] has declined for three consecutive quarters, with an average year-over-year change of +14.20 percentage points over the last seven quarters.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 23.11% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 12.34% |
| 10 | enGene Therapeutics | 161.50 Mn | -832.97 Mn | - | -50.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -50.80% |
| Apr 30, 2026 | -45.10% |
| Jan 31, 2026 | -51.34% |
| Jul 31, 2025 | -42.61% |
| Apr 30, 2025 | -33.55% |
| Jan 31, 2025 | -27.46% |
| Oct 31, 2024 | -22.68% |
| Jul 31, 2024 | -21.30% |
| Apr 30, 2024 | -25.54% |
| Jan 31, 2024 | -38.52% |
| Oct 31, 2023 | -183.99% |
API Access
enGene Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();